ArticleCurrent cancer drug targets2024

Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer.

Ying Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.